Market rumours have been vindicated with Conquest Mining reporting ‘spectacular drilling results’, with more to come.
Have analysts had enough? It must be time to stop believing Newcrest’s Telfer is ever going to live up to its supposed potential.
A 23% increase in gold reserves is not as exciting as it sounds.
Yesterday’s CPI data resulted in reduced expectations of a February rate rise, but there are still arguments inflationary pressures remain in the Australian economy.
T3 provided a “truce”, but now that’s put to bed Telstra is back in fighting mode, taking the ACCC to court on a constitutional challenge.
The fall in the December quarter CPI has led economists to suggest the RBA will not raise rates next month, but will rather take to the sidelines with a watchful eye.
Improved performance in its key essential mail division allowed HPAL to beat earnings expectations, but upgrades to forecasts have not led to upgraded ratings.
UBS analysts point out that Alumina Ltd is already trading below its NPV and replacement cost, but cost blow-outs for Alcan imply even greater value.
News Corp will be added to Macquarie’s recommended list shortly, a source tells us.
Austock suggests any sale by Merck of its generic drug maker Alphapharm would lift competition in the Australian market as the new owner would move to stem market share losses.